Novartis and Medicines for Malaria Venture (MMV) announced the launch of Coartem® Dispersible, a new pediatric formulation of Coartem® (artemether/lumefantrine 20 mg/120 mg), for the treatment of uncomplicated malaria in infants and children.
-
31Jan
-
31Jan
For patients with a particularly aggressive form of skin cancer malignant melanoma stress, including that which comes from simply hearing that diagnosis, might amplify the progression of their disease.
-
31Jan
Does shift work predispose you to cancer by altering the body’s response to hormones? And if so, can a dietary supplement help? Those are the questions researchers at The Cancer Institute of New Jersey (CINJ) hope to answer through a new study, which recently received $600,000 in funding from The V Foundation for Cancer Research.
-
31Jan
Screening a chemical library of 200,000 compounds, researchers at UT Southwestern Medical Center have identified two new classes that can be used to study and possibly manipulate a cellular pathway involved in many types of cancer and degenerative diseases.
-
31Jan
A team of researchers at the University of California, San Diego (UCSD) and the Moores UCSD Cancer Center have developed a rapid, automated image screening process to distinguish breast cancer cells from normal cells.
Tags: Breast Cancer, Cancer, Research
-
31Jan
An Internet program helps to reduce depressive symptoms and prevent episodes of clinical depression in adolescent patients at risk, reports a study in the February issue of the Journal of Developmental & Behavioral Pediatrics.
Tags: Depression
-
31Jan
Brief but personal intervention reduces drinking among risky college drinkers, according to a research study at The University of Texas School of Public Health. Results of the study will be published in the February issue of the Journal of Consulting and Clinical Psychology.
-
31Jan
A century-old drug that failed in its original intent to treat tuberculosis but has worked well as an antileprosy medicine now holds new promise as a potential therapy for multiple sclerosis and other autoimmune diseases.
Tags: Drug
-
31Jan
A survey study believed to be one of the first efforts to put hard numbers around long-held beliefs about diversity in medical school faculties has affirmed that awareness and sensitivity to racial and ethnic diversity are believed by most faculty to be poor and even poorer among faculty who are members of underrepresented minorities.
-
31Jan
Almost 5,000 people escaped their frigid homes last night in American Red Cross shelters in areas where utility companies are working to restore power to more than 770,000 homes and businesses still in the dark after this week’s storm. With new snow on the ground and a chilly weekend approaching, that number could grow as more cold weather grips the nation.
Tags: Cold
-
31Jan
New research has shown that companies can take advantage of opportunities and manage risk by collecting and understanding intelligence through the competitive or business intelligence function.
Tags: Research
-
31Jan
Biology exists in a physical world. That’s a fact cancer researchers are beginning to recognize as they look to include concepts of physics and mathematics in their efforts to understand how cancer develops — and how to stop it.
-
31Jan
AdvanDx announced it received FDA 510(k) clearance for E. coli/P. aeruginosa PNA FISH(R) to identify Escherichia coli and/or Pseudomonas aeruginosa directly from positive blood cultures. E. coli/P. aeruginosa PNA FISH is the first-ever test for identifying E. coli and P.
-
31Jan
eResearchTechnology, Inc. (ERT), (Nasdaq: ERES), and Integrium, LLC announced their alliance to provide integrated Cardiac Safety and Ambulatory Blood Pressure Monitoring centralized core laboratory services to clinical trial sponsors and managers worldwide.
Tags: Research
-
31Jan
Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low Perfusion pulse oximetry, announced that a new multi-center study of 39,821 newborns was published in the January 2009 issue of the British Medical Journal (BMJ).
Tags: Heart
-
31Jan
Pro-Pharmaceuticals, Inc. (OTCBB: PRWP) announced that the U.S. Food & Drug Administration (FDA), in a pre-New Drug Application (NDA) meeting held last December, indicated the Company will be required to conduct a Phase III trial to demonstrate superiority to the best standard of care for late stage colorectal cancer patients.
-
31Jan
In a new study, Cymbalta (duloxetine HCl) 60-120 mg, taken once daily, reduced pain severity significantly, compared with placebo, in patients with osteoarthritis pain of the knee. Data from the 13-week randomized, double-blind, placebo-controlled clinical trial(1) were presented at the annual meeting of the American Academy of Pain Medicine (AAPM) in Honolulu, Hawaii.
Tags: Arthritis
-
31Jan
Calling this period “an unparalleled opportunity” for change, an influential group of medical leaders today urged the nation’s medical schools to reform their educational model because it too often fails to give new physicians the right mix of competencies and experiences to practice medicine effectively.
-
31Jan
Scientists have uncovered an interesting connection between two important protein kinase signaling pathways that are associated with cancer. The research, published by Cell Press in the January 30th issue of the journal Molecular Cell, may direct new therapeutic strategies for multiple types of cancer.
-
31Jan
The humble tadpole could provide the key to developing effective anti-skin cancer drugs, thanks to a groundbreaking discovery by researchers at the University of East Anglia (UEA).
Recent Comments